
Xcell Therapeutics Inc. — Investor Relations & Filings
Xcell Therapeutics Inc. is a company specializing in the research, development, and production of advanced cell culture media. Its primary product line, CellCor™, consists of serum-free, chemically defined media designed to provide an optimal environment for cell culture, particularly for mesenchymal stem cells (MSCs). The technology aims to enhance efficiency and yield for researchers and developers in the fields of cell therapy and regenerative medicine. By offering a serum-free alternative, the company provides a more consistent and defined solution compared to traditional media. Xcell Therapeutics is also expanding its services to become a Contract Development and Manufacturing Organization (CDMO) and is exploring applications for its media in the cultured meat sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]사업보고서 (2025.12) | 2026-05-15 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 기업설명회(IR)개최 | 2026-04-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | |
| [기재정정]주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46348401 | [기재정정]사업보고서 (2025.12) | 2026-05-15 | Korean | ||
| 46348392 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34546589 | 기업설명회(IR)개최 | 2026-04-15 | Korean | ||
| 33135306 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33135251 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33129738 | [기재정정]주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean | ||
| 33129688 | 주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean | ||
| 33129656 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-01 | Korean | ||
| 33084598 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-30 | Korean | ||
| 33084339 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-30 | Korean | ||
| 33058275 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33057987 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33055592 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 32996034 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-20 | Korean | ||
| 32984488 | 감사보고서제출 | 2026-03-19 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
Xcell Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16801/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16801 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16801 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16801 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16801}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xcell Therapeutics Inc. (id: 16801)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.